{'fraction_non_alphanumeric': 0.03436123348017621, 'fraction_numerical': 0.033480176211453744, 'mean_word_length': 5.491428571428571, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 1, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Anaplastic Large Cell Lymphoma Occurring in Women with Breast Implants: Analysis of 173 Cases, and Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Systematic Review.

Anaplastic Large Cell Lymphoma Occurring in Women with Breast Implants: Analysis of 173 Cases, and Breast Implant–Associated Anaplastic Large Cell Lymphoma: A Systematic Review Sir: W read with great interest the article by Dr. Garry Brody et al. entitled “Anaplastic Large Cell Lymphoma Occurring in Women with Breast Implants: Analysis of 173 Cases,” published online on December 8, 2014, along with the article by Dr. Courtney Gidengil et al., “Breast Implant–Associated Anaplastic Large Cell Lymphoma: A Systematic Review,” and the associated discussions for both articles.1–6 We commend Dr. Brody on publishing his data, as we fully support transparent data sharing in the effort to better understand this rare condition. Allergan remains interested in elucidating the cause, diagnosis, and treatment of breast implant– associated anaplastic large cell lymphoma and is committed to supporting this important research. DOI: 10.1097/PRS.0000000000001350